• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

退伍军人健康管理局中社区获得性肺炎的临床和经济负担,2011年:一项回顾性队列研究

Clinical and economic burden of community-acquired pneumonia in the Veterans Health Administration, 2011: a retrospective cohort study.

作者信息

McLaughlin John M, Johnson Maribeth H, Kagan Stephen A, Baer Stephanie L

机构信息

Pfizer Vaccines, New York, NY, USA.

, PO BOX 113, Powell, OH, 43065, USA.

出版信息

Infection. 2015 Dec;43(6):671-80. doi: 10.1007/s15010-015-0789-3. Epub 2015 May 17.

DOI:10.1007/s15010-015-0789-3
PMID:25980561
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4656694/
Abstract

PURPOSE

The burden of community-acquired pneumonia (CAP) is not well described in the US Veterans Health Administration (VHA).

METHODS

CAP was defined as having a pneumonia diagnosis with evidence of chest X-ray, and no evidence of prior (90 days) hospitalization/long-term care. We calculated incidence rates of adult CAP occurring in inpatient or outpatient VHA settings in 2011. We also estimated the proportion of VHA CAP patients who were hospitalized, were readmitted within 30 days of hospital discharge, and died (any cause) in the year following diagnosis. Incremental costs during the 90 days following a CAP diagnosis were estimated from the perspective of the VHA.

RESULTS

In 2011, 34,101 Veterans developed CAP (35,380 episodes) over 7,739,757 VHA person-years. Median age of CAP patients was 65 years (95 % male). CAP incidence rates were higher for those aged ≥50 years. A majority of Veterans aged 50-64 (53 %) and ≥65 (66 %) years had ≥1 chronic medical (moderate risk) or immunocompromising (high risk) condition. Compared to those at low-risk (healthy), moderate- and high-risk Veterans were >3 and >6 times more likely to develop CAP, respectively. The percentage of CAP patients who were hospitalized was 45 %, ranging from 12 % (age 18-49, low risk) to 57 % (age ≥65, high risk). One-year all-cause mortality rates ranged from 1 % (age 18-49, low risk) to 36 % (age ≥65, high risk). Annual VHA medical expenditure related to CAP was estimated to be $750 million (M) ($415M for those aged ≥65 years).

CONCLUSION

A focus on CAP prevention among older Veterans and those with comorbid or immunocompromising conditions is important.

摘要

目的

美国退伍军人健康管理局(VHA)中社区获得性肺炎(CAP)的负担情况尚未得到充分描述。

方法

CAP被定义为有肺炎诊断且有胸部X光证据,且无既往(90天内)住院/长期护理证据。我们计算了2011年在VHA住院或门诊环境中发生的成人CAP发病率。我们还估计了VHA中因CAP住院的患者比例、出院后30天内再次入院的比例以及诊断后一年内死亡(任何原因)的比例。从VHA的角度估计了CAP诊断后90天内的增量成本。

结果

2011年,在7739757个VHA人年中,有34101名退伍军人发生了CAP(35380例)。CAP患者的中位年龄为65岁(95%为男性)。年龄≥50岁者的CAP发病率更高。50 - 64岁(53%)和≥65岁(66%)的退伍军人中,大多数患有≥1种慢性疾病(中度风险)或免疫功能低下(高风险)疾病。与低风险(健康)人群相比,中度和高风险退伍军人发生CAP的可能性分别高出3倍和6倍以上。因CAP住院的患者比例为45%,范围从12%(18 - 49岁,低风险)到57%(≥65岁,高风险)。一年全因死亡率范围从1%(18 - 49岁,低风险)到36%(≥65岁,高风险)。VHA每年与CAP相关的医疗支出估计为7.5亿美元(65岁及以上人群为4.15亿美元)。

结论

关注老年退伍军人以及患有合并症或免疫功能低下疾病的人群预防CAP很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5456/4656694/6d87734e98f4/15010_2015_789_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5456/4656694/dcaba42ab7c7/15010_2015_789_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5456/4656694/14aef6ceaa83/15010_2015_789_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5456/4656694/68201a820a31/15010_2015_789_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5456/4656694/6d87734e98f4/15010_2015_789_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5456/4656694/dcaba42ab7c7/15010_2015_789_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5456/4656694/14aef6ceaa83/15010_2015_789_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5456/4656694/68201a820a31/15010_2015_789_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5456/4656694/6d87734e98f4/15010_2015_789_Fig4_HTML.jpg

相似文献

1
Clinical and economic burden of community-acquired pneumonia in the Veterans Health Administration, 2011: a retrospective cohort study.退伍军人健康管理局中社区获得性肺炎的临床和经济负担,2011年:一项回顾性队列研究
Infection. 2015 Dec;43(6):671-80. doi: 10.1007/s15010-015-0789-3. Epub 2015 May 17.
2
Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.社区获得性肺炎住院患者的发病率、直接费用及住院时长:一项全国性回顾性索赔数据库分析
Vaccine. 2015 Jun 22;33(28):3193-9. doi: 10.1016/j.vaccine.2015.05.001. Epub 2015 May 14.
3
CAPECO: Cost evaluation of community acquired pneumonia managed in primary care.CAPECO:初级保健中社区获得性肺炎的成本评估。
Vaccine. 2016 Apr 27;34(19):2275-80. doi: 10.1016/j.vaccine.2016.03.013. Epub 2016 Mar 12.
4
Clinical and economic burden of community-acquired pneumonia in the Medicare fee-for-service population.医疗保险按服务项目付费人群中社区获得性肺炎的临床和经济负担。
J Am Geriatr Soc. 2012 Nov;60(11):2137-43. doi: 10.1111/j.1532-5415.2012.04208.x. Epub 2012 Oct 30.
5
Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.估算美国社区获得性肺炎患者住院时间缩短半天所产生的经济影响。
Curr Med Res Opin. 2009 Sep;25(9):2151-7. doi: 10.1185/03007990903102743.
6
Burden of hospitalized childhood community-acquired pneumonia: A retrospective cross-sectional study in Vietnam, Malaysia, Indonesia and the Republic of Korea.儿童社区获得性肺炎住院负担:越南、马来西亚、印度尼西亚和大韩民国的回顾性横断面研究。
Hum Vaccin Immunother. 2018 Jan 2;14(1):95-105. doi: 10.1080/21645515.2017.1375073. Epub 2017 Nov 10.
7
Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years.50 岁及以上商业保险美国成年人中按年龄和风险划分的社区获得性肺炎发作费用。
Appl Health Econ Health Policy. 2013 Jun;11(3):251-8. doi: 10.1007/s40258-013-0026-0.
8
The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study.社区获得性肺炎(CAP)住院患者的年度经济负担:一项回顾性美国队列研究。
Curr Med Res Opin. 2020 Jan;36(1):151-160. doi: 10.1080/03007995.2019.1675149. Epub 2019 Oct 17.
9
Treatment costs of community-acquired pneumonia in an employed population.就业人群中社区获得性肺炎的治疗费用。
Chest. 2004 Jun;125(6):2140-5. doi: 10.1378/chest.125.6.2140.
10
Disease burden of hospitalized community-acquired pneumonia in South Korea: Analysis based on age and underlying medical conditions.韩国住院社区获得性肺炎的疾病负担:基于年龄和基础疾病的分析。
Medicine (Baltimore). 2017 Nov;96(44):e8429. doi: 10.1097/MD.0000000000008429.

引用本文的文献

1
Disease burden and high-risk populations for complications in patients with acute respiratory infections: a scoping review.急性呼吸道感染患者的疾病负担及并发症高危人群:一项范围综述
Front Med (Lausanne). 2024 May 16;11:1325236. doi: 10.3389/fmed.2024.1325236. eCollection 2024.
2
A Sequent of Gram-Negative Co-Infectome-Induced Acute Respiratory Distress Syndrome Are Potentially Subtle Aggravators Associated to the SARS-CoV-2 Evolution of Virulence.革兰氏阴性菌合并感染诱发的急性呼吸窘迫综合征的一个后果可能是与SARS-CoV-2毒力演变相关的潜在细微加重因素。
Diagnostics (Basel). 2024 Jan 4;14(1):120. doi: 10.3390/diagnostics14010120.
3

本文引用的文献

1
Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adults.13价肺炎球菌结合疫苗预防成人肺炎球菌肺炎:CAPiTA,成人社区获得性肺炎免疫试验
Hum Vaccin Immunother. 2015;11(7):1825-7. doi: 10.1080/21645515.2015.1043502.
2
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.多糖结合疫苗预防成人肺炎球菌性肺炎。
N Engl J Med. 2015 Mar 19;372(12):1114-25. doi: 10.1056/NEJMoa1408544.
3
Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Molecular and Source-Specific Profiling of Hospital Reveal Dominance of Skin Infection and Age-Specific Selections in Pediatrics and Geriatrics.
医院感染的分子及来源特异性分析揭示皮肤感染的主导地位以及儿科和老年医学中特定年龄组的感染情况。
Microorganisms. 2023 Jan 6;11(1):149. doi: 10.3390/microorganisms11010149.
4
Clinical and economic burden of pneumococcal disease among individuals aged 16 years and older in Germany.德国 16 岁及以上人群中肺炎球菌性疾病的临床和经济负担。
Epidemiol Infect. 2022 Nov 8;150:e204. doi: 10.1017/S0950268822001182.
5
Comparison between Ceftriaxone and Sulbactam-Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis.头孢曲松与舒巴坦-氨苄西林作为社区获得性肺炎初始治疗的比较:一项系统评价和荟萃分析
Antibiotics (Basel). 2022 Sep 22;11(10):1291. doi: 10.3390/antibiotics11101291.
6
How and when to manage respiratory infections out of hospital.如何以及何时管理院外呼吸道感染。
Eur Respir Rev. 2022 Oct 19;31(166). doi: 10.1183/16000617.0092-2022. Print 2022 Dec 31.
7
Systematic review and meta-analysis of comorbidities and associated risk factors in Indian patients of community-acquired pneumonia.印度社区获得性肺炎患者合并症及相关危险因素的系统评价和荟萃分析。
SAGE Open Med. 2022 Apr 29;10:20503121221095485. doi: 10.1177/20503121221095485. eCollection 2022.
8
Effectiveness of Beta-Lactam plus Doxycycline for Patients Hospitalized with Community-Acquired Pneumonia.β-内酰胺联合多西环素治疗社区获得性肺炎住院患者的疗效。
Clin Infect Dis. 2022 Aug 24;75(1):118-124. doi: 10.1093/cid/ciab863.
9
Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low- and middle-income countries.低收入和中等收入国家成人疫苗可预防疾病的情况评估以及免疫宣传与政策的潜力。
Vaccine. 2021 Mar 12;39(11):1556-1564. doi: 10.1016/j.vaccine.2021.01.066. Epub 2021 Feb 19.
10
Accelerating the sustainable development goals through microbiology: some efforts and opportunities.通过微生物学加速可持续发展目标:一些努力与机遇
Access Microbiol. 2020 Mar 23;2(5):acmi000112. doi: 10.1099/acmi.0.000112. eCollection 2020.
《65 岁及以上成人中使用 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗:免疫实践咨询委员会(ACIP)的建议》。
MMWR Morb Mortal Wkly Rep. 2014 Sep 19;63(37):822-5.
4
The incidence rate and economic burden of community-acquired pneumonia in a working-age population.工作年龄人群社区获得性肺炎的发病率和经济负担。
Am Health Drug Benefits. 2013 Sep;6(8):494-503.
5
Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae.左氧氟沙星耐药肺炎链球菌引起的侵袭性感染的危险因素和临床意义。
Infection. 2013 Oct;41(5):935-9. doi: 10.1007/s15010-013-0481-4. Epub 2013 May 25.
6
30-day mortality in UK patients with bacteraemic community-acquired pneumonia.英国菌血症性社区获得性肺炎患者的 30 天死亡率。
Infection. 2013 Oct;41(5):1005-11. doi: 10.1007/s15010-013-0462-7. Epub 2013 May 24.
7
Clinical and economic burden of community-acquired pneumonia in the Medicare fee-for-service population.医疗保险按服务项目付费人群中社区获得性肺炎的临床和经济负担。
J Am Geriatr Soc. 2012 Nov;60(11):2137-43. doi: 10.1111/j.1532-5415.2012.04208.x. Epub 2012 Oct 30.
8
Reliance on Veterans Affairs outpatient care by Medicare-eligible veterans.符合医疗保险条件的退伍军人对退伍军人事务部门诊护理的依赖。
Med Care. 2011 Oct;49(10):911-7. doi: 10.1097/MLR.0b013e31822396c5.
9
Clinical and economic burden of community-acquired pneumonia amongst adults in the Asia-Pacific region.亚太地区成人社区获得性肺炎的临床和经济负担。
Int J Antimicrob Agents. 2011 Aug;38(2):108-17. doi: 10.1016/j.ijantimicag.2011.02.017. Epub 2011 Jun 16.
10
Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality.住院社区获得性肺炎患者的危险因素和严重程度评分:严重程度和死亡率的预测。
Eur J Clin Microbiol Infect Dis. 2012 Jan;31(1):33-47. doi: 10.1007/s10096-011-1272-4. Epub 2011 May 1.